The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)186-189
    Number of pages4
    JournalClinical Oncology
    Volume8
    Issue number3
    Publication statusPublished - 1996

    Keywords

    • Antineoplastic Agents
    • Drug Design
    • Drug Resistance, Neoplasm
    • Genes, Tumor Suppressor
    • Genes, myc
    • Genes, p53
    • Genetic Therapy
    • Humans
    • Neoplasms
    • Oncogenes

    Cite this

    @article{2207b74f159e49209b2a6a11fef1565b,
    title = "The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology",
    keywords = "Antineoplastic Agents, Drug Design, Drug Resistance, Neoplasm, Genes, Tumor Suppressor, Genes, myc, Genes, p53, Genetic Therapy, Humans, Neoplasms, Oncogenes",
    author = "Petty, {R. D.}",
    year = "1996",
    language = "English",
    volume = "8",
    pages = "186--189",
    journal = "Clinical Oncology",
    issn = "0936-6555",
    publisher = "Elsevier",
    number = "3",

    }

    TY - JOUR

    T1 - The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs

    T2 - its role in the improvement of selective toxicity and the development of new drugs in clinical oncology

    AU - Petty, R. D.

    PY - 1996

    Y1 - 1996

    KW - Antineoplastic Agents

    KW - Drug Design

    KW - Drug Resistance, Neoplasm

    KW - Genes, Tumor Suppressor

    KW - Genes, myc

    KW - Genes, p53

    KW - Genetic Therapy

    KW - Humans

    KW - Neoplasms

    KW - Oncogenes

    M3 - Article

    C2 - 8814375

    VL - 8

    SP - 186

    EP - 189

    JO - Clinical Oncology

    JF - Clinical Oncology

    SN - 0936-6555

    IS - 3

    ER -